163 related articles for article (PubMed ID: 30980967)
1. Immune deviation and cervical carcinogenesis.
Smola S
Papillomavirus Res; 2019 Jun; 7():164-167. PubMed ID: 30980967
[TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.
Smola S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28895886
[TBL] [Abstract][Full Text] [Related]
3. Immune evasion mechanisms of human papillomavirus: An update.
Steinbach A; Riemer AB
Int J Cancer; 2018 Jan; 142(2):224-229. PubMed ID: 28865151
[TBL] [Abstract][Full Text] [Related]
4. hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
de Freitas AC; de Oliveira THA; Barros MR; Venuti A
J Exp Clin Cancer Res; 2017 May; 36(1):71. PubMed ID: 28545552
[TBL] [Abstract][Full Text] [Related]
5. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
7. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
Conesa-Zamora P
Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
[TBL] [Abstract][Full Text] [Related]
8. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
Sasagawa T; Takagi H; Makinoda S
J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
[TBL] [Abstract][Full Text] [Related]
9. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
Barros MR; de Oliveira THA; de Melo CML; Venuti A; de Freitas AC
J Immunol Res; 2018; 2018():2912671. PubMed ID: 29854832
[TBL] [Abstract][Full Text] [Related]
10. [Persistent human papillomavirus infection in the etiology of cervical carcinoma: the role of immunological, genetic, viral and cellular factors].
Zivadinović R; Petrić A; Lilić G; Lilić V; Djordjević B
Srp Arh Celok Lek; 2014; 142(5-6):378-83. PubMed ID: 25033599
[TBL] [Abstract][Full Text] [Related]
11. Host immune responses to cervical cancer.
Patel S; Chiplunkar S
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):54-9. PubMed ID: 19125004
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
13. Is there a role played by HLA-E, if any, in HPV immune evasion?
Franciosi JR; Gelmini GF; Roxo VS; de Carvalho NS; Bicalho MDG
Scand J Immunol; 2020 Mar; 91(3):e12850. PubMed ID: 31733115
[TBL] [Abstract][Full Text] [Related]
14. [Papillomavirus infections and cervical tumorigenesis].
Kiyono T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):227-31. PubMed ID: 20235389
[No Abstract] [Full Text] [Related]
15. Human papillomavirus and cervical cancer.
Schiffman M; Castle PE; Jeronimo J; Rodriguez AC; Wacholder S
Lancet; 2007 Sep; 370(9590):890-907. PubMed ID: 17826171
[TBL] [Abstract][Full Text] [Related]
16. [Escape mechanisms to the innate immune response in HPV-associated cervical cancer].
del Toro-Arreola S; García-Chagollán M; Jave-Suárez LF
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S194-9. PubMed ID: 26462516
[TBL] [Abstract][Full Text] [Related]
17. The role of inflammation in HPV carcinogenesis.
Boccardo E; Lepique AP; Villa LL
Carcinogenesis; 2010 Nov; 31(11):1905-12. PubMed ID: 20819779
[TBL] [Abstract][Full Text] [Related]
18. Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
Mehta AM; Mooij M; Branković I; Ouburg S; Morré SA; Jordanova ES
J Immunol Res; 2017; 2017():8913860. PubMed ID: 28280748
[TBL] [Abstract][Full Text] [Related]
19. APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.
Chen L; Qiu X; Zhang N; Wang Y; Wang M; Li D; Wang L; Du Y
Biosci Trends; 2017 Sep; 11(4):383-388. PubMed ID: 28717061
[TBL] [Abstract][Full Text] [Related]
20. Evasion of host immune defenses by human papillomavirus.
Westrich JA; Warren CJ; Pyeon D
Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
